Amgen LinkedIn Live Event Looks at Multispecific Medicines

Amgen’s first-ever LinkedIn Live event featured a conversation between Ray Deshaies, Amgen’s Senior VP for Global Research, and Carolyn Bertozzi, a Professor of Chemistry at Stanford University, investigator of the Howard Hughes Medical Institute, and Baker Family Co-Director at Stanford ChEM-H. In the event, held on October 5, 2020, Ray and Carolyn explored the future of multispecific medicines, and their discussion was viewed live by more than 500 people around the world.

To watch the replay, visit Amgen’s LinkedIn page to view the discussion at this link.

Subscribe for the latest from Amgen Science.

System error message. Lorem ipsum.
I authorize Amgen and its contractors to use my email address and provide me with updates, informational material, and/or contact me about Amgen Science. I understand that my email address will not be used for any other purposes. I understand that receiving these communications is optional and free and that I have the ability to opt out at anytime. For more information, please see the Amgen privacy policy.